Key Statistics for 93MV
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (EUR) (ttm)
|Est. EPS (EUR) (12/2013)
|Est. PEG Ratio
|Market Cap (M EUR)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (EUR)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 93MV
- Net Income (M/EUR)
MPH Mittelstaendische Pharma Holding AG operates as a holding company in the pharmaceutical industry. The Company's core business is the direct purchase of existing shares in pharmaceutical companies and the creation and development of businesses that operate in the core segment generics, parallel importing, logistics and pharmaceutical wholesalers.
More Company Profile & Key Executives for 93MV
|Patrick BrenskeMember-Mgmt Board||Christian PahlMember-Mgmt Board|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries